Premarket Movers | Revolution Medicines Jumps 16%; Tilray Gains 7%; Semiconductor Equipment Shares Jump With ASML Up 3%; AXT Falls 13% on Lowered Sales Outlook

Tiger Newspress
01/09

Revolution Medicines, Inc. jumped over 16% in premarket trading as Merck is in talks to buy it, the Financial Times reported on Thursday, citing people familiar with the matter.

Semiconductor equipment shares jumped in premarket trading with ASML up 3%, Lam Research up 1.3%.

AXT shares dropped after the company cut its revenue outlook, citing China's reduction of export control permits. The stock shed 13% to $22.45 in premarket trading. Through the close, shares were up nearly fivefold over the past three months.

Tilray Inc. rose 7% in premarket trading after announcing a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10